Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience.

Multiple sclerosis and related disorders·2026
Same author

Evaluation of the performance of large language models in responding to medical questions related to multiple sclerosis: A case study of large language models including ChatGPT, Gemini, Grok and Copilot.

PloS one·2026
Same author

The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD.

The Lancet. Neurology·2026
Same author

Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines.

CNS drugs·2026
Same author

Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.

Journal of the neurological sciences·2026
Same journal

The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.

eNeurologicalSci·2026
Same journal

Correlation of the monocyte to high-density lipoprotein cholesterol ratio and neutrophil to high-density lipoprotein cholesterol ratio with the severity of acute ischemic stroke.

eNeurologicalSci·2026
Same journal

Painful tic convulsif: Dual neurovascular compression within the spectrum of cranial nerve hyperactive dysfunction syndromes.

eNeurologicalSci·2026
Same journal

Nitrous oxide-related neurotoxicity: Clinical features, key investigations, and a proposed diagnostic approach from a single-center cohort.

eNeurologicalSci·2026
Same journal

Fractures beyond spasms: Progressive encephalomyelitis with rigidity and myoclonus associated with GABA-linked bone fragility.

eNeurologicalSci·2026
Same journal

Response to "Comment on 'Prevalence and risk factors of paediatric seizures in COVID-19 infection: A study from Thailand'".

eNeurologicalSci·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.8K

Update in multiple sclerosis.

Bassem Yamout1

  • 1Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.

Eneurologicalsci
|February 3, 2025
PubMed
Summary
This summary is machine-generated.

Multiple Sclerosis (MS) is a central nervous system disorder with increasing global prevalence. This review covers evolving insights into MS causes, diagnosis, and rapidly advancing treatments.

Keywords:
DiagnosisEpidemiologyMultiple sclerosisPregnancyTherapy

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Related Experiment Videos

Last Updated: May 9, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.8K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Area of Science:

  • Neurology
  • Immunology
  • Epidemiology

Background:

  • Multiple Sclerosis (MS) is a chronic demyelinating disorder of the central nervous system (CNS).
  • MS predominantly affects individuals aged 20-40 years, with changing global epidemiology.
  • Emerging evidence suggests a multifactorial etiology involving genetic and environmental factors.

Purpose of the Study:

  • To provide a comprehensive overview of Multiple Sclerosis (MS).
  • To cover recent advances in MS epidemiology, immunopathogenesis, diagnosis, and therapeutics.
  • To discuss updated treatment guidelines and disease management strategies.

Main Methods:

  • Review of current literature on MS epidemiology and etiology.
  • Analysis of recent diagnostic criteria and therapeutic advancements.
  • Synthesis of information on disease management, including pregnancy and updated guidelines.

Main Results:

  • MS prevalence and incidence are increasing worldwide.
  • New concepts in immunopathogenesis point to multifactorial causes.
  • Significant therapeutic advances have occurred, with novel disease-modifying therapies (DMTs) available.

Conclusions:

  • Understanding MS etiology and epidemiology is crucial for effective management.
  • Rapid advancements in MS therapeutics require updated treatment guidelines.
  • Comprehensive management strategies are essential for optimizing patient outcomes in MS.